Evidence map›Paper›PMID 30030907›Full record

ArticleCancer medicine2018

Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.

Dorian R A Swarts, Quirinus J M Voorham, Annina P van Splunter, Saskia M Wilting, Daoud Sie, Divera Pronk, Marc van Beurden, Daniëlle A M Heideman, Peter J F Snijders, Chris J L M Meijer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Vulval premalignant lesions: a review article.Obstetrics & gynecology science · 2024
    Article
  6. Article
  7. Article
  8. Molecular Landscape of Vulvar Squamous Cell Carcinoma.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Dorian R A SwartsCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-7927-7613
Quirinus J M VoorhamCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
Annina P van SplunterCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
Saskia M WiltingCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
Daoud SieCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-6762-2582
Divera PronkCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
Marc van BeurdenDepartment of Gynecology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Daniëlle A M HeidemanCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-6463-7391
Peter J F SnijdersCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-2758-9463
Renske D M SteenbergenCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-2327-9839
Maaike C G BleekerCancer Center Amsterdam, Department of Pathology, VU University Medical Center, VU University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0001-9610-8064
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulvar squamous cell carcinoma (VSCC) and precancerous vulvar intraepithelial neoplasia (VIN) can develop through human papillomavirus (HPV)-dependent and -independent pathways, indicating a heterogeneous disease. Only a minority of VIN progress, but current clinicopathological classifications are insufficient to predict the cancer risk. Here we analyzed copy number alterations (CNA) to assess the molecular heterogeneity of vulvar lesions in relation to HPV and cancer risk. HPV-status and CNA by means of whole-genome next-generation shallow-sequencing were assessed in VSCC and VIN. The latter included VIN of women with associated VSCC (VIN

Indexed as

Cell Transformation, NeoplasticCell Transformation, ViralPapillomaviridaeBiomarkersCarcinoma, Squamous CellDisease ProgressionDNA Copy Number VariationsFemaleHumansImmunohistochemistryNeoplasm StagingPapillomavirus InfectionsPrecancerous ConditionsVulvar NeoplasmsBiomarkerscopy number alterationshuman papillomavirusprogression riskvulvar intraepithelial neoplasiavulvar squamous cell carcinoma

Identifiers

PMID30030907
PMCPMC6144162
OpenAlexW2884164952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.